Pioglitazone in Clinical Practice: Where Are We Now?

Pioglitazone, a thiazolidinedione, improves insulin sensitivity and thus reduces blood glucose. Clinical trials have suggested potential cardiovascular outcome benefits in association with pioglitazone; however, safety concerns are mounting, with recent data suggesting a link between pioglitazone an...

Descripción completa

Detalles Bibliográficos
Autores principales: Govindan, Joytish, Evans, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare Communications 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508118/
https://www.ncbi.nlm.nih.gov/pubmed/22373598
http://dx.doi.org/10.1007/s13300-012-0001-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3508118/
https://www.ncbi.nlm.nih.gov/pubmed/22373598
http://dx.doi.org/10.1007/s13300-012-0001-z

Ejemplares similares